Home > Antibody > Marker Primary Antibody > Rabbit Anti-phospho-Kv4.2 (Thr607)/AF647 Conjugated antibody

Rabbit Anti-phospho-Kv4.2 (Thr607)/AF647 Conjugated antibody

Rabbit Anti-phospho-Kv4.2 (Thr607)/AF647 Conjugated antibody
Total

Product Summary

Alias:p-KCND2/Kv4.2(Thr607); p-Kv4.2(Thr607); Potassium voltage-gated channel subfamily D member 2; KCD2; KCND 2; KCND2; KCND2_HUMAN; KIAA1044; Potassium voltage gated channel Shal related subfamily member 2; RK 5; RK5; Voltage gated potassium channel Kv4.2; Vo

NO.:SL20293R-AF647

Clonality:Polyclonal

Immunogen Species:Rabbit

React Species:Rat(predicted:Human,Mouse,Pig,Cow,Rabbit)

Applications:IF

concentration:1mg/ml

    Number:

Details

Product Name Anti-phospho-Kv4.2 (Thr607)/AF647
Chinese Name AF647标记的磷酸化电压门控性钾Channel proteinKv4.2抗体
Alias p-KCND2/Kv4.2(Thr607); p-Kv4.2(Thr607); Potassium voltage-gated channel subfamily D member 2; KCD2; KCND 2; KCND2; KCND2_HUMAN; KIAA1044; Potassium voltage gated channel Shal related subfamily member 2; RK 5; RK5; Voltage gated potassium channel Kv4.2; Voltage gated potassium channel subunit Kv4.2; Voltage sensitive potassium channel; voltage-gated potassium channel Kv4.2; Voltage-gated potassium channel subunit Kv4.2; voltage-sensitive potassium channel.
Product Type Phosphorylated anti
Research Area Cardiovascular Neurobiology Channel protein
Immunogen Species Rabbit
Clonality Polyclonal
React Species Rat(predicted:Human,Mouse,Pig,Cow,Rabbit)
Applications IF=1:100-500
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
Molecular weight 70kDa
Form Lyophilized or Liquid
Concentration 1mg/ml
immunogen KLH conjugated synthesised phosphopeptide derived from human KCND2 around the phosphorylation site of Thr607
Lsotype IgG
Purification affinity purified by Protein A
Storage Buffer 1M TBS(pH7.4) with 1% BSA, 3% Proclin300 and 50% Glycerol.
Storage Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 1M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Product Detail background:
Voltage-gated K+ channels in the plasma membrane control the repolarization and the frequency of action potentials in neurons, muscles, and other excitable cells. Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits.

Function:
Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits.

Subunit:
Homotetramer or heterotetramer with KCND1 and/or KCND3. Interacts with DPP6, DLG4 and NCS1/FREQ (By similarity). Interacts with DLG1. Associates with the regulatory subunits KCNIP1, KCNIP2, KCNIP3 and KCNIP4. Probably part of a complex consisting of KCNIP1, KCNIP2 isoform 3 and KCND2. The KCND2-KCNIP2 channel complex contains four KCND2 and four KCNIP2 subunits. Interacts with FLNA, FLNC and DPP10.

Subcellular Location:
Cell membrane. Cell projection > dendrite. Detected in dendrites in cultured hippocampal neurons. Association with KCNIP2 probably enhances cell surface expression.

Tissue Specificity:
Highly expressed throughout the brain. Expression is very low or absent in other tissues.

Post-translational modifications:
Phosphorylated on serine and threonine residues.

Similarity:
Belongs to the potassium channel family. D (Shal) (TC 1.A.1.2) subfamily. Kv4.2/KCND2 sub-subfamily.

Database links:

Entrez Gene: 3751 Human

Omim: 605410 Human

SwissProt: Q9NZV8 Human

Unigene: 654739 Human



Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

Partial purchase records (2)

UsernameQuantitybought time
Ja***12024-05-25
Mi***22023-11-14
Total 2 records, divided into1 pages. First Prev Next Last

Leave a message

* To protect against spam, please pass the CAPTCHA test below.

Newsletter

Sign up
0 0